Publishing vaccine trial results – Does there have to be a delay? by McShane, H, Tameris, D, Landry, B, Snowden, M, Lockhart, S, Scriba, T, Mahomed, H, Hatherill, M

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M

From Standardization to Specificity: A Retrospective Analysis of Adverse Event Classification in Neurological Clinical Research by Katherine M. Landry, B.S., Matthew J. Gooden, M.S., Sandra B. Martin, M.S., Henry Roberts, Ph.D., Lauren B. Reoma, M.D.

Get full text

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hanekom, W, Mahomed, H, McShane, H

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination by Bunyasi, E, Luabeya, A, Tameris, M, Geldenhuys, H, Mulenga, H, Landry, B, Scriba, T, Schmidt, B, Hanekom, W, Mahomed, H, McShane, H, Hatherill, M

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study by Andrews, J, Nemes, E, Tameris, M, Landry, B, Mahomed, H, McClain, J, Fletcher, H, Hanekom, W, Wood, R, McShane, H, Scriba, T, Hatherill, M

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children by Mcshane, H, Tameris, M, Luabeya, K, Geldenhuys, H, Scriba, T, Hussey, G, Mahomed, H, Landry, B, Hanekom, W, Hatherill, M, Toefey, A, Hughes, E, Van Schalkwyk, A

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial by Tameris, MD, Hatherill, M, Landry, B, Scriba, T, Snowden, M, Lockhart, S, Lockhart, S, Shea, J, McClain, J, Hussey, G, Hussey, G, Hanekom, W, Mahomed, H, Mahomed, H, McShane, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, Van Der Merwe, L, De Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study by Seydou Doumbia, Kadari Cisse, Henri Gautier Ouedraogo, Dewi Ismajani Puradiredja, Jürgen May, Ralf Krumkamp, Daniela Fusco, Sylvain Landry B. Faye, Moctar Tounkara, Ricardo Strauss, Tani Sagna, Alpha Mahmoud Barry, Abdul Karim Mbawah, Cheick Oumar Doumbia, Souleymane Diouf, Mohamed Harding, Paule Donven

Get full text

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated... by Sheehan, S, Harris, SA, Satti, I, Hokey, DA, Dheenadhayalan, V, Stockdale, L, Thomas, Z-R, Minhinnick, A, Wilkie, M, Vermaak, S, Meyer, J, O'Shea, MK, Pau, MG, Versteege, I, Douoguih, M, Hendriks, J, Sadoff, J, Landry, B, Moss, P, McShane, H

Cytomegalovirus infection is a risk factor for TB disease in infants by Müller, J, Tanner, R, Matsumiya, M, Snowden, MA, Landry, B, Satti, I, Harris, SA, O'Shea, MK, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Thomas, Z-R, Stylianou, E, Naranbhai, V, Mbandi, SK, Hatherill, M, Hussey, G, Mahomed, H, Tameris, M, McClain, JB, Hanekom, WA, Evans, TG, Scriba, TJ, McShane, H

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants. by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H

T-cell activation is an immune correlate of risk in BCG vaccinated infants by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H